Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk

✍ Scribed by The European Nicotinamide Diabetes Intervention Trial (ENDIT) Group; P. J. Bingley; E. A. M. Gale

• Publisher: Springer
• Year: 2006
• Tongue: English
• Weight: 170 KB
• Volume: 49
• Category: Article
• ISSN: 0012-186X
• DOI: 10.1007/s00125-006-0160-4